Our
Projects
Interested in reading more of our case studies?
​
Email lorelai@neuro-nw.com for more information!
Disruption of Cognitive Functions in Psychiatric Conditions
Cognitive functions, such as memory, attention, executive function, and emotional regulation, are often impaired in psychiatric conditions like generalized anxiety disorder, major depressive disorder, and bipolar disorder. These disruptions significantly impact daily functioning and quality of life. Understanding the neurobiological mechanisms that underlie cognitive dysfunction and how various treatments—both pharmacological and behavioral—can alleviate these disruptions is critical in advancing psychiatric care.
Harnessing Intrinsic Motivators and Meaningful Engagement for Sustainable Behavior Change in Behavioral Health
This case study explores how integrating novel gamified elements into behavioral health apps can drive long-term behavior change, particularly for individuals managing chronic conditions and mental health disorders. By leveraging intrinsic motivators—such as autonomy, competence, and relatedness—these apps tap into the psychological principles that enhance user engagement and adherence. Positive reinforcement loops, such as immediate feedback, rewards, and progress tracking, further bolster sustained engagement, creating a cycle of motivation and achievement. The integration of these elements not only promotes adherence to treatment plans but also enhances mental resilience, offering a promising approach to improving outcomes in chronic care management.
The Evolution of Digital Therapeutics: A Comparative Analysis of Leading U.S. Companies in the Sector
The digital therapeutics (DTx) industry has emerged as a transformative force in healthcare, blending technology and clinical treatments to address chronic conditions and mental health disorders. Companies like Pear Therapeutics, Omada Health, Akili Interactive, and Better Therapeutics have led this revolution, offering software-based interventions that focus on patient behavior change, cognitive retraining, and data-driven personalized care. While these companies have pioneered innovative approaches, they face challenges in regulatory approval, market adoption, and financial sustainability. This study compares the growth, strategies, and challenges of these leading digital therapeutics companies, highlighting key lessons learned and projecting the future of the industry.
